VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 9, 2007) - Allon Therapeutics Inc. (TSX:NPC), The Neuro Protection CompanyTM, announced today that the journal Expert Opinions in Investigational Drugs recently published an expert review by Allon’s scientific team of novel drugs in development for Alzheimer’s disease. The invited review “Looking for novel ways to treat the hallmarks of Alzheimer’s disease”, describes a range of new drugs but focuses on strategies that break new ground. The review shows clearly that the high potential approaches are those dealing with the underlying causes of the disease.
